CN106222201A - 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 - Google Patents
一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 Download PDFInfo
- Publication number
- CN106222201A CN106222201A CN201610744414.4A CN201610744414A CN106222201A CN 106222201 A CN106222201 A CN 106222201A CN 201610744414 A CN201610744414 A CN 201610744414A CN 106222201 A CN106222201 A CN 106222201A
- Authority
- CN
- China
- Prior art keywords
- cell
- car
- cord blood
- positive
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Abstract
Description
组别 | 给药细胞 | 给药体积(μL) | 给药量(个/只) |
空白组 | 无(PBS) | 200 | 0 |
阴性对照组 | 脐带血T细胞 | 200 | 1×106 |
实验I组 | 脐带血CAR-T细胞 | 200 | 1×106 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610744414.4A CN106222201B (zh) | 2016-08-27 | 2016-08-27 | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610744414.4A CN106222201B (zh) | 2016-08-27 | 2016-08-27 | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106222201A true CN106222201A (zh) | 2016-12-14 |
CN106222201B CN106222201B (zh) | 2017-11-28 |
Family
ID=57555018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610744414.4A Active CN106222201B (zh) | 2016-08-27 | 2016-08-27 | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106222201B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107523550A (zh) * | 2017-08-08 | 2017-12-29 | 安徽惠恩生物科技股份有限公司 | 一种针对小细胞肺癌的Car‑T细胞制备方法 |
CN107904259A (zh) * | 2017-11-01 | 2018-04-13 | 上海隆耀生物科技有限公司 | 一种治疗艾滋病合并淋巴瘤的car‑t细胞及其制备方法和应用 |
CN108239623A (zh) * | 2016-12-23 | 2018-07-03 | 上海恒润达生生物科技有限公司 | 一种混合cart细胞的制备方法和应用 |
CN108315298A (zh) * | 2018-02-07 | 2018-07-24 | 安徽古生物科技有限公司 | 一种γδT细胞的培养方法 |
CN108660113A (zh) * | 2018-05-21 | 2018-10-16 | 杭州启澜生物医学技术有限公司 | 一种制备改良型car-t细胞的方法 |
CN108728415A (zh) * | 2017-04-17 | 2018-11-02 | 沈阳美达博生物科技有限公司 | 一种利用cd3制备car-t细胞的方法 |
CN108949825A (zh) * | 2018-07-30 | 2018-12-07 | 苏州茂行生物科技有限公司 | 一种靶向her2的car-t细胞的制备方法及应用 |
CN109337930A (zh) * | 2018-09-30 | 2019-02-15 | 北京鼎成肽源生物技术有限公司 | 一种afft1细胞 |
CN109385402A (zh) * | 2017-08-11 | 2019-02-26 | 上海恒润达生生物科技有限公司 | 一种等比例混合两种靶点cart细胞的制备方法及应用 |
CN110157683A (zh) * | 2019-05-29 | 2019-08-23 | 南京艾德免疫治疗研究院有限公司 | 一种治疗白血病的car-t细胞制剂的制备方法 |
CN111154720A (zh) * | 2020-01-14 | 2020-05-15 | 南京鼓楼医院 | 一种car-t培养基及其应用 |
CN112375740A (zh) * | 2020-11-16 | 2021-02-19 | 苏州米苏生物技术有限公司 | Car-t细胞培养基及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012050374A2 (en) * | 2010-10-13 | 2012-04-19 | Innocell, Inc. | Immunotherapy for solid tumors |
WO2013074916A1 (en) * | 2011-11-18 | 2013-05-23 | Board Of Regents, The University Of Texas System | Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
WO2015188119A1 (en) * | 2014-06-06 | 2015-12-10 | Bluebird Bio, Inc. | Improved t cell compositions |
CN105408473A (zh) * | 2013-05-14 | 2016-03-16 | 得克萨斯州大学***董事会 | 工程化嵌合抗原受体(car)t细胞的人应用 |
US20160228547A1 (en) * | 2015-02-06 | 2016-08-11 | Batu Biologics, Inc. | Chimeric antigen receptor targeting of tumor endothelium |
US20160237407A1 (en) * | 2015-02-17 | 2016-08-18 | Batu Biologics, Inc. | Universal donor chimeric antigen receptor cells |
-
2016
- 2016-08-27 CN CN201610744414.4A patent/CN106222201B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012050374A2 (en) * | 2010-10-13 | 2012-04-19 | Innocell, Inc. | Immunotherapy for solid tumors |
WO2013074916A1 (en) * | 2011-11-18 | 2013-05-23 | Board Of Regents, The University Of Texas System | Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
CN105408473A (zh) * | 2013-05-14 | 2016-03-16 | 得克萨斯州大学***董事会 | 工程化嵌合抗原受体(car)t细胞的人应用 |
WO2015188119A1 (en) * | 2014-06-06 | 2015-12-10 | Bluebird Bio, Inc. | Improved t cell compositions |
US20160228547A1 (en) * | 2015-02-06 | 2016-08-11 | Batu Biologics, Inc. | Chimeric antigen receptor targeting of tumor endothelium |
US20160237407A1 (en) * | 2015-02-17 | 2016-08-18 | Batu Biologics, Inc. | Universal donor chimeric antigen receptor cells |
Non-Patent Citations (1)
Title |
---|
D.WATSON等: "14-Initial Comparisons of Three Apheresis Platforms for Supporting the Collection of CD3+ Cell for CAR-T Production", 《CYTOTHERAPY》 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108239623A (zh) * | 2016-12-23 | 2018-07-03 | 上海恒润达生生物科技有限公司 | 一种混合cart细胞的制备方法和应用 |
CN108239623B (zh) * | 2016-12-23 | 2020-03-24 | 上海恒润达生生物科技有限公司 | 一种混合cart细胞的制备方法和应用 |
CN108728415A (zh) * | 2017-04-17 | 2018-11-02 | 沈阳美达博生物科技有限公司 | 一种利用cd3制备car-t细胞的方法 |
CN107523550A (zh) * | 2017-08-08 | 2017-12-29 | 安徽惠恩生物科技股份有限公司 | 一种针对小细胞肺癌的Car‑T细胞制备方法 |
CN109385402A (zh) * | 2017-08-11 | 2019-02-26 | 上海恒润达生生物科技有限公司 | 一种等比例混合两种靶点cart细胞的制备方法及应用 |
CN107904259A (zh) * | 2017-11-01 | 2018-04-13 | 上海隆耀生物科技有限公司 | 一种治疗艾滋病合并淋巴瘤的car‑t细胞及其制备方法和应用 |
CN108315298B (zh) * | 2018-02-07 | 2020-10-20 | 安徽古一生物科技有限公司 | 一种γδT细胞的培养方法 |
CN108315298A (zh) * | 2018-02-07 | 2018-07-24 | 安徽古生物科技有限公司 | 一种γδT细胞的培养方法 |
CN108660113A (zh) * | 2018-05-21 | 2018-10-16 | 杭州启澜生物医学技术有限公司 | 一种制备改良型car-t细胞的方法 |
CN108949825A (zh) * | 2018-07-30 | 2018-12-07 | 苏州茂行生物科技有限公司 | 一种靶向her2的car-t细胞的制备方法及应用 |
CN109337930A (zh) * | 2018-09-30 | 2019-02-15 | 北京鼎成肽源生物技术有限公司 | 一种afft1细胞 |
CN109337930B (zh) * | 2018-09-30 | 2020-10-30 | 北京鼎成肽源生物技术有限公司 | 一种afft1细胞 |
CN110157683A (zh) * | 2019-05-29 | 2019-08-23 | 南京艾德免疫治疗研究院有限公司 | 一种治疗白血病的car-t细胞制剂的制备方法 |
CN111154720A (zh) * | 2020-01-14 | 2020-05-15 | 南京鼓楼医院 | 一种car-t培养基及其应用 |
CN111154720B (zh) * | 2020-01-14 | 2020-12-25 | 南京鼓楼医院 | 一种car-t培养基及其应用 |
CN112375740A (zh) * | 2020-11-16 | 2021-02-19 | 苏州米苏生物技术有限公司 | Car-t细胞培养基及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106222201B (zh) | 2017-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106222201A (zh) | 一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用 | |
EP2794859B1 (en) | Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same | |
CN105087487B (zh) | 一种高效扩增cik的方法 | |
ES2391573T3 (es) | Método para el tratamiento de activación de una célula presentadora de antígeno | |
CN106544365B (zh) | 一种人抗cd19嵌合抗原受体修饰的cik的制备方法及应用 | |
CN107384949B (zh) | 表达GPC3嵌合抗原受体的iNKT细胞及制备、应用 | |
CN107043749B (zh) | 一种肿瘤浸润t淋巴细胞的分离诱导方法 | |
Peng et al. | Tumor‐associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma | |
CN105274053B (zh) | 一种高细胞毒活性的cik细胞的制备方法 | |
CN109422815A (zh) | 双特异性嵌合抗原受体c-Met/PD-1 scFv-CAR-T及其构建方法和应用 | |
CN108949685A (zh) | 一种体外诱导扩增高杀伤活性γδT细胞的方法 | |
US11834677B2 (en) | Expansion and use of expanded NK cell fractions | |
CN106554416A (zh) | 一种抗pd-l1人源化单克隆抗体联合干扰素基因刺激蛋白(sting)激动剂在抗肿瘤中的应用 | |
CN104894072B (zh) | 一种自体自然杀伤细胞增殖的制备方法及其应用 | |
CN107699591A (zh) | 一种敲除pd‑1的t细胞制备方法及其应用 | |
CN109568351B (zh) | 溶瘤病毒和car-t联合应用针对实体肿瘤的治疗 | |
CN116769723B (zh) | 一种gd2嵌合抗原受体修饰的t细胞及其应用 | |
CN109957543A (zh) | 利用脐带血大量扩增脐血nk细胞的方法 | |
JP5301994B2 (ja) | Lak細胞の増殖方法 | |
CN109642214A (zh) | 用于有效活化nkt细胞的技术 | |
CN110292630A (zh) | 一种nk细胞和cd20+靶点抗体的组合物及在淋巴瘤上应用 | |
CN106047810A (zh) | 一种新型DC‑CTLs细胞培养体系及其培养方法 | |
CN116509834A (zh) | 化合物在制备造血干/祖细胞增殖和损伤修复药物中的应用 | |
CN113116878A (zh) | 15s-hepe用于增强t细胞介导的肿瘤免疫治疗的新用途 | |
CN116574194A (zh) | 嵌合抗原受体及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 316, floor 3, building 1, block B, No. 80, xingshikou Road, Haidian District, Beijing 100093 Patentee after: Beijing Yimiao Shenzhou Pharmaceutical Technology Co., Ltd Address before: 100000 , Tsinghua Park, Tsinghua University, research and research building, eight floor, B, Beijing Patentee before: BEIJING IMMUNO SHENZHOU MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161214 Assignee: Shanghai xianbo Biotechnology Co., Ltd Assignor: Beijing Yimiao Shenzhou Pharmaceutical Technology Co.,Ltd. Contract record no.: X2020320000048 Denomination of invention: A method for preparing car-t cells, the prepared car-t cells and their application Granted publication date: 20171128 License type: Exclusive License Record date: 20200722 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Shanghai xianbo Biotechnology Co., Ltd Assignor: Beijing Yimiao Shenzhou Pharmaceutical Technology Co.,Ltd. Contract record no.: X2020320000048 Date of cancellation: 20211218 |
|
EC01 | Cancellation of recordation of patent licensing contract |